standard

Scancell reports Phase 2 data showing strongly improved outcomes in Late-Stage Melanoma with its Immunobody iSCIB1+

July 22, 2025 02:00 ET  | Source: Scancell Holdings Plc SCOPE trial of SCIB1/iSCIB1+ plus standard of care shows excellent…

4 days ago

Bridge Capture enables sensitive, scalable liquid biopsy in colorectal cancer pilot

Clinical study in Scientific Reports shows Bridge Capture™ detects key mutations from blood samples in metastatic colorectal cancer patients TURKU,…

2 weeks ago

The Lamborghini Temerario GT3 Born and bred in SantAgata Bolognese

Introducing the first race car derived from the Temerario road modelFirst competition model entirely designed and developed by Lamborghini in…

2 weeks ago

Kia Announces Pricing for 2026 Kia K5

Kia America has announced pricing for the 2026 Kia K5. A boldly styled sedan designed to deliver thrilling performance, premium…

2 weeks ago

Medidata and the University of Sydney’s NHMRC Clinical Trials Centre Broaden Efforts to Revolutionize Clinical Studies in Australia

Continuing collaboration will utilize the capabilities of the Medidata Data Experience, fostering efficiency, fast-tracking research breakthroughs, and raising the standard…

2 weeks ago

Revenera Achieves ISO 27001 Certification of its Information Security Management System (ISMS)

ITASCA, Ill., July 09, 2025 (GLOBE NEWSWIRE) -- Revenera, a division of Flexera Software LLC and producer of innovative platforms…

2 weeks ago

Novotech Earns Frost & Sullivan’s 2025 Global Company of the Year Recognition for Excellence in Biotech Clinical Research Services

Recognized for its biotech-first focus, innovation in clinical trial delivery, and best-in-class client experience, Novotech sets the global standard in…

3 weeks ago

The Ensign Group Purchases Skilled Nursing Facility in Texas

July 02, 2025 06:00 ET  | Source: The Ensign Group, Inc. SAN JUAN CAPISTRANO, Calif., July 02, 2025 (GLOBE NEWSWIRE)…

3 weeks ago

The Ensign Group Continues Growth in Idaho

July 02, 2025 06:00 ET  | Source: The Ensign Group, Inc. SAN JUAN CAPISTRANO, Calif., July 02, 2025 (GLOBE NEWSWIRE)…

3 weeks ago

QIAGEN and Incyte Announce Precision Medicine Collaboration to Develop Companion Diagnostics for Patients With Mutant CALR-expressing Myeloproliferative Neoplasms (MPNs)

QIAGEN to create a multimodal panel using next-generation sequencing (NGS) technology for detecting clinically relevant gene alterations in hematological malignancies…

1 month ago